These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Elevated serum prolactin concentrations in phenylketonuric patients on a 'loose diet'. Schulpis KH; Papakonstantinou E; Michelakakis H; Theodoridis T; Papandreou U; Constantopoulos A Clin Endocrinol (Oxf); 1998 Jan; 48(1):99-101. PubMed ID: 9509074 [TBL] [Abstract][Full Text] [Related]
3. Morning preprandial plasma ghrelin and catecholamine concentrations in patients with phenylketonuria and normal controls: evidence for catecholamine-mediated ghrelin regulation. Schulpis KH; Papassotiriou I; Vounatsou M; Karikas GA; Tsakiris S; Chrousos GP J Clin Endocrinol Metab; 2004 Aug; 89(8):3983-7. PubMed ID: 15292337 [TBL] [Abstract][Full Text] [Related]
4. Biotin recycling impairment in phenylketonuric children with seborrheic dermatitis. Schulpis KH; Nyalala JO; Papakonstantinou ED; Leondiadis L; Livaniou E; Ithakisios D; Georgala S Int J Dermatol; 1998 Dec; 37(12):918-21. PubMed ID: 9888332 [TBL] [Abstract][Full Text] [Related]
5. Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Schulpis KH; Tsakiris S; Traeger-Synodinos J; Papassotiriou I Clin Biochem; 2005 Mar; 38(3):239-42. PubMed ID: 15708545 [TBL] [Abstract][Full Text] [Related]
6. Effect of diet on plasma total antioxidant status in phenylketonuric patients. Schulpis KH; Tsakiris S; Karikas GA; Moukas M; Behrakis P Eur J Clin Nutr; 2003 Feb; 57(2):383-7. PubMed ID: 12571675 [TBL] [Abstract][Full Text] [Related]
7. In vivo effects of high phenylalanine blood levels on Na+,K+-ATPase, Mg2+-ATPase activities and biogenic amine concentrations in phenylketonuria. Schulpis KH; Tjamouranis J; Karikas GA; Michelakakis H; Tsakiris S Clin Biochem; 2002 Jun; 35(4):281-5. PubMed ID: 12135689 [TBL] [Abstract][Full Text] [Related]
8. Reduced acetylcholinesterase activity in erythrocyte membranes from patients with phenylketonuria. Tsakiris S; Schulpis KH; Tjamouranis J; Michelakakis H; Karikas GA Clin Biochem; 2002 Nov; 35(8):615-9. PubMed ID: 12498995 [TBL] [Abstract][Full Text] [Related]
10. The effects of sapropterin on urinary monoamine metabolites in phenylketonuria. Douglas TD; Jinnah HA; Bernhard D; Singh RH Mol Genet Metab; 2013 Jul; 109(3):243-50. PubMed ID: 23712020 [TBL] [Abstract][Full Text] [Related]
11. Haemostatic variables in phenylketonuric children under dietary treatment. Schulpis KH; Platokouki H; Papakonstantinou ED; Adamtziki E; Bargeliotis A; Aronis S J Inherit Metab Dis; 1996; 19(5):603-9. PubMed ID: 8892015 [TBL] [Abstract][Full Text] [Related]
12. Increased plasma adiponectin concentrations in poorly controlled patients with phenylketonuria normalize with a strict diet: evidence for catecholamine-mediated adiponectin regulation and a complex effect of phenylketonuria diet on atherogenesis risk factors. Schulpis KH; Papassotiriou I; Tsakiris S; Vounatsou M; Chrousos GP Metabolism; 2005 Oct; 54(10):1350-5. PubMed ID: 16154435 [TBL] [Abstract][Full Text] [Related]
13. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet. Schulpis KH; Karakonstantakis T; Bartzeliotou A; Karikas GA; Papassotiriou I Clin Nutr; 2004 Jun; 23(3):401-7. PubMed ID: 15158304 [TBL] [Abstract][Full Text] [Related]
14. Plasma cholesterol in adults with phenylketonuria. Williams RA; Hooper AJ; Bell DA; Mamotte CD; Burnett JR Pathology; 2015 Feb; 47(2):134-7. PubMed ID: 25551302 [TBL] [Abstract][Full Text] [Related]
15. Positive effect of a simplified diet on blood phenylalanine control in different phenylketonuria variants, characterized by newborn BH4 loading test and PAH analysis. Zimmermann M; Jacobs P; Fingerhut R; Torresani T; Thöny B; Blau N; Baumgartner MR; Rohrbach M Mol Genet Metab; 2012 Jul; 106(3):264-8. PubMed ID: 22607939 [TBL] [Abstract][Full Text] [Related]
16. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients. Sitta A; Manfredini V; Biasi L; Treméa R; Schwartz IV; Wajner M; Vargas CR Mutat Res; 2009; 679(1-2):13-6. PubMed ID: 19665577 [TBL] [Abstract][Full Text] [Related]
17. L-carnitine blood levels and oxidative stress in treated phenylketonuric patients. Sitta A; Barschak AG; Deon M; de Mari JF; Barden AT; Vanzin CS; Biancini GB; Schwartz IV; Wajner M; Vargas CR Cell Mol Neurobiol; 2009 Mar; 29(2):211-8. PubMed ID: 18814025 [TBL] [Abstract][Full Text] [Related]